» Articles » PMID: 36494348

Selective Posttranslational Inhibition of Caβ-associated Voltage-dependent Calcium Channels with a Functionalized Nanobody

Abstract

Ca influx through high-voltage-activated calcium channels (HVACCs) controls diverse cellular functions. A critical feature enabling a singular signal, Ca influx, to mediate disparate functions is diversity of HVACC pore-forming α and auxiliary Caβ-Caβ subunits. Selective Caα blockers have enabled deciphering their unique physiological roles. By contrast, the capacity to post-translationally inhibit HVACCs based on Caβ isoform is non-existent. Conventional gene knockout/shRNA approaches do not adequately address this deficit owing to subunit reshuffling and partially overlapping functions of Caβ isoforms. Here, we identify a nanobody (nb.E8) that selectively binds Caβ SH3 domain and inhibits Caβ-associated HVACCs by reducing channel surface density, decreasing open probability, and speeding inactivation. Functionalizing nb.E8 with Nedd4L HECT domain yielded Chisel-1 which eliminated current through Caβ-reconstituted Ca1/Ca2 and native Ca1.1 channels in skeletal muscle, strongly suppressed depolarization-evoked Ca influx and excitation-transcription coupling in hippocampal neurons, but was inert against Caβ-associated Ca1.2 in cardiomyocytes. The results introduce an original method for probing distinctive functions of ion channel auxiliary subunit isoforms, reveal additional dimensions of Caβ signaling in neurons, and describe a genetically-encoded HVACC inhibitor with unique properties.

Citing Articles

Nanobody-thioesterase chimeras to specifically target protein palmitoylation.

Kuo C, Gok C, Fulton H, Dickson-Murray E, Adu S, Gallen E Nat Commun. 2025; 16(1):1445.

PMID: 39920166 PMC: 11805987. DOI: 10.1038/s41467-025-56716-x.


Peptide and Peptidomimetic Inhibitors Targeting the Interaction of Collapsin Response Mediator Protein 2 with the N-Type Calcium Channel for Pain Relief.

Perez-Miller S, Gomez K, Khanna R ACS Pharmacol Transl Sci. 2024; 7(7):1916-1936.

PMID: 39022365 PMC: 11249630. DOI: 10.1021/acsptsci.4c00181.


Ion channel inhibition by targeted recruitment of NEDD4-2 with divalent nanobodies.

Morgenstern T, Darko-Boateng A, Afriyie E, Shanmugam S, Zhou X, Choudhury P bioRxiv. 2024; .

PMID: 38854018 PMC: 11160594. DOI: 10.1101/2024.05.28.596281.


Aberrant expression of NEDD4L disrupts mitochondrial homeostasis by downregulating CaMKKβ in diabetic kidney disease.

Han F, Wu S, Dong Y, Liu Y, Sun B, Chen L J Transl Med. 2024; 22(1):465.

PMID: 38755664 PMC: 11100153. DOI: 10.1186/s12967-024-05207-6.


Regulating voltage-gated ion channels with nanobodies.

Manning D, Santana L Nat Commun. 2022; 13(1):7557.

PMID: 36494383 PMC: 9734093. DOI: 10.1038/s41467-022-35027-5.

References
1.
Robison P, Sussan T, Chen H, Biswal S, Schneider M, Hernandez-Ochoa E . Impaired calcium signaling in muscle fibers from intercostal and foot skeletal muscle in a cigarette smoke-induced mouse model of COPD. Muscle Nerve. 2016; 56(2):282-291. PMC: 5426995. DOI: 10.1002/mus.25466. View

2.
Morgenstern T, Park J, Fan Q, Colecraft H . A potent voltage-gated calcium channel inhibitor engineered from a nanobody targeted to auxiliary Caβ subunits. Elife. 2019; 8. PMC: 6701945. DOI: 10.7554/eLife.49253. View

3.
Opatowsky Y, Chen C, Campbell K, Hirsch J . Structural analysis of the voltage-dependent calcium channel beta subunit functional core and its complex with the alpha 1 interaction domain. Neuron. 2004; 42(3):387-99. DOI: 10.1016/s0896-6273(04)00250-8. View

4.
Wheeler D, Groth R, Ma H, Barrett C, Owen S, Safa P . Ca(V)1 and Ca(V)2 channels engage distinct modes of Ca(2+) signaling to control CREB-dependent gene expression. Cell. 2012; 149(5):1112-24. PMC: 3654514. DOI: 10.1016/j.cell.2012.03.041. View

5.
Kanner S, Morgenstern T, Colecraft H . Sculpting ion channel functional expression with engineered ubiquitin ligases. Elife. 2017; 6. PMC: 5764571. DOI: 10.7554/eLife.29744. View